BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2010

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2010-01-01 to 2010-12-31
Filed
2011-11-15
IRS object ID
201113199349307796
Schema version
2010v3.4
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2011-11-15T15:22:01-06:00Timestamp
Tax Period End Date2010-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1LARSONALLEN LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line12900 SOUTH QUINCY ST SUITE 150AddressLine1
CityARLINGTONCity
StateVAState
ZIP Code22206ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2010-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INDUSTRY ORGANIZATIONBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlBIOTNameControl
Phone2029629200Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameA SCOTT WHITAKERName
TitleCHIEF OPERATING OFFICERTitle
Phone2029629200Phone
Date Signed2011-11-15DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameKAREN GRIESName
Phone7039985100Phone
FieldValueIRS element (for citing)
Tax Year2010TaxYear
Build TS2016-03-07 17:11:31ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonJAMES C GREENWOODNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW NO 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode
FieldValueIRS element (for citing)
Gross Receipts124430495GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501cXOrganization501c
Web SiteWWW.BIO.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1993YearFormation
State Legal DomicileDCStateLegalDomicile
Activity Or Mission DescriptionBIOTECHNOLOGY RESEARCHERS EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND BY PROVIDING BETTER HEALTHCARE, ENHANCED AGRICULTURE, AND A CLEANER AND SAFER ENVIRONMENT. THE MISSION OF BIO IS TO BE THE CHAMPION OF BIOTECHNOLOGY AND THE ADVOCATE FOR ITS MEMBER ORGANIZATIONS - BOTH LARGE AND SMALL.ActivityOrMissionDescription
Nbr Voting Members Governing Body109NbrVotingMembersGoverningBody
Nbr Independent Voting Members109NbrIndependentVotingMembers
Total Nbr Employees182TotalNbrEmployees
Total Nbr Volunteers109TotalNbrVolunteers
Total Gross UBI271792TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year0ContributionsGrantsPriorYear
Contributions Grants Current Year0ContributionsGrantsCurrentYear
Program Service Revenue Prior Year55354873ProgramServiceRevenuePriorYear
Program Service Revenue CY57498909ProgramServiceRevenueCY
Investment Income Prior Year1356296InvestmentIncomePriorYear
Investment Income Current Year3478235InvestmentIncomeCurrentYear
Other Revenue Prior Year301100OtherRevenuePriorYear
Other Revenue Current Year42100OtherRevenueCurrentYear
Total Revenue Prior Year57012269TotalRevenuePriorYear
Total Revenue Current Year61019244TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year0GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY0GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year24221558SalariesEtcPriorYear
Salaries Etc Current Year23396161SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year0TotalFundrsngExpCurrentYear
Other Expense Prior Year39174981OtherExpensePriorYear
Other Expenses Current Year35354014OtherExpensesCurrentYear
Total Expenses Prior Year63396539TotalExpensesPriorYear
Total Expenses Current Year58750175TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-6384270RevenuesLessExpensesPriorYear
Revenues Less Expenses CY2269069RevenuesLessExpensesCY
Total Assets BOY61748284TotalAssetsBOY
Total Assets EOY65414013TotalAssetsEOY
Total Liabilities BOY25354585TotalLiabilitiesBOY
Total Liabilities EOY26464995TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY36393699NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY38949018NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionTHE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) REPRESENTS MORE THAN 1,100 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIOTECHNOLOGY INDUSTRY ORGANIZATION IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIOTECHNOLOGY INDUSTRY ORGANIZATION MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIOTECHNOLOGY INDUSTRY ORGANIZATION'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
DescriptionADVOCACYBIOTECHNOLOGY INDUSTRY ORGANIZATION'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIOTECHNOLOGY INDUSTRY ORGANIZATION BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIOTECHNOLOGY INDUSTRY ORGANIZATION MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2010 ARE LISTED BELOW. - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT ETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE EMERGING COMPANIES SECTION PRESSES FOR RULES FAVORABLE TO SMALL COMPANIES IN AREAS SUCH AS TAX POLICY, FINANCIAL REPORTING AND ACCOUNTING LAW AND REGULATIONS, AND FEDERAL GRANTS. THE EMERGING COMPANIES SECTION'S 2010 ADVOCACY ACCOMPLISHMENTS ARE LISTED BELOW.- ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- INCREASED OPPORTUNITIES FOR SMALL COMPANIES TO RECEIVE FEDERAL GRANTS.- ADVOCATED FOR TAX POLICY SUPPORTING INNOVATIVE EMERGING COMPANIES.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS.- INFLUENCED HEALTH CARE POLICY TO REFLECT THE CONCERNS OF SMALL BIOTECHNOLOGY COMPANIES.THE FOOD & AGRICULTURE SECTION FOCUSES ON MAINTAINING A SCIENCE-BASED REGULATORY ENVIRONMENT FOR BIOTECH CROPS AND EMERGING PRODUCTS, SUCH AS PLANT- AND ANIMAL-MADE PHARMACEUTICALS AND FEEDSTOCKS FOR BIOFUELS. SOME OF THE FOOD AND AGRICULTURE SECTION'S 2010 ADVOCACY ACCOMPLISHMENTS ARE LISTED BELOW.- SHORED UP FDA POLICY ON LABELING OF AGRICULTURAL PRODUCTS DERIVED FROM BIOTECHNOLOGY.- COORDINATED ADVOCACY RESULTING IN JAPAN FIXING ITS STALLED REGULATORY PROCESS.- ADVOCATED FOR STRONG U.S. GOVERNMENT OUTREACH TO OTHER COUNTRIES IN SUPPORT OF INDUSTRY POSITIONS FOR THE BIOSAFETY PROTOCOL.-ADVOCATED FOR STRONG U.S. GOVERNMENT ENGAGEMENT WITH EU ON PLANT AND ANIMAL BIOTECHNOLOGY.-SUCCESSFULLY OUTREACHED STAKEHOLDERS ON BENEFITS AND USES OF BIOTECHNOLOGY INCLUDING THROUGH STEWARDSHIP PROGRAMS.-PUBLIC RECOGNITION BY KEY APPOINTEES AT USDA AND STATE DEPARTMENT FOR BIOTECHNOLOGY'S CONTRIBUTIONS TO SUSTAINABLE AGRICULTURE.THE HEALTH SECTION DRIVES ADVOCACY TO ENSURE THAT PATIENTS HAVE ACCESS TO THE FRUITS OF BIOTECH RESEARCH, WHILE MAINTAINING THE MARKETPLACE REWARDS THAT DRIVE CONTINUED INNOVATION. BELOW ARE THE HEALTH SECTION'S 2010 ACCOMPLISHMENTS.- IMPROVED THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- ENHANCED PATIENT ACCESS TO INNOVATIVE THERAPIES.- ENSURED THAT BIOSIMILARS POLICIES PROTECT PATIENT SAFETY AND PROMOTE BIOMEDICAL INNOVATION.- PROMOTED DEVELOPMENT AND USE OF RESEARCH TOOLS, MOLECULAR DIAGNOSTICS AND PERSONALIZED THERAPIES.- ADVOCATED FOR POLICIES THAT FOSTER VACCINE INNOVATION AND PROMOTE PANDEMIC AND BIO-DEFENSE PREPAREDNESS.- IMPROVED THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION.THE INDUSTRIAL & ENVIRONMENTAL SECTION ADVOCATES FOR INCENTIVES THAT HELP CREATE MARKET DEMAND FOR CUTTING-EDGE CONSUMER PRODUCTS SUCH AS GREEN PLASTICS, RENEWABLE FUELS AND CHEMICALS AND HEALTHIER FOODS. BELOW ARE THE INDUSTRIAL & ENVIRONMENTAL SECTION'S 2010 ADVOCACY ACCOMPLISHMENTS.BIOFUELS- ADVOCATED FOR GRANTS AND LOAN GUARANTEES ISSUED TO ADVANCED AND CELLULOSIC BIOFUELS PROJECTS.- ADVANCED BIOFUELS TAX PACKAGE INTRODUCED IN HOUSE (HR 5142) WITH 50+ COSPONSORS. - HELPED SECURE A STRONG BIOMASS CROP ASSISTANCE PROGRAM FINAL RULE.- ADVOCATED FOR PROGRESS ON USDA AND DOE LOAN GUARANTEES.- ADVOCATED FOR MODIFICATION TO RENEWABLE FUEL STANDARD FINAL RULE.BIOBASED PRODUCTS- EDUCATED CONGRESS ON THE DRAFT BIOBASED TAX LEGISLATION AND ITS IMPACT ON JOB CREATION AND GROWING THE U.S. CHEMICAL INDUSTRY.BIO HOLDS TWO INDUSTRIAL BIOTECH CONFERENCES EACH YEAR; THE WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY AND BIOPROCESSING, AND THE PACIFIC RIM SUMMIT ON INDUSTRIAL BIOTECHNOLOGY AND BIOENERGY.THE PACIFIC RIM SUMMIT ON INDUSTRIAL BIOTECHNOLOGY & BIOENERGY WAS HELD IN DECEMBER 2010 IN HONOLULU, HI, AND HAD 355 ATTENDEES. THE SUMMIT IS WHERE "EAST MEETS WEST" IN THE RAPIDLY EXPANDING APPLICATION OF INDUSTRIAL BIOTECHNOLOGY. THE CONFERENCE HIGHLIGHTS RECENT ADVANCES IN BIOTECHNOLOGY FOR BIOENERGY, RENEWABLE CHEMICALS, MICROBIOLOGY, ENZYMES, BIOBASED PRODUCTS, ENERGY CROPS, MARINE BIOTECH, SYNTHETIC BIOLOGY, MANUFACTURING AND PROCESSING. TECHNICAL TRACKS, PLENARY SESSIONS AND PRIVATE ONE-ON-ONE BUSINESS PARTNERING MEETINGS ARE HELD DURING THE CONFERENCE. THE WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY & BIOPROCESSINGWAS HELD N MAY 2010 IN WASHINGTON, D.C., WITH 950 ATTENDEES. THIS CONFERENCE IS A INTERDISCIPLINARY FORUM PRESENTING THE LATEST DEVELOPMENTS IN INDUSTRIAL BIOTECHNOLOGY FOR ADVANCED BIOFUELS, RENEWABLE CHEMICALS, BIOBASED MATERIALS, AND BIOTECH-BASED MANUFACTURING AND PROCESSING. IT INCLUDES TECHNICAL TRACKS, PLENARY SESSIONS, INVESTOR SESSIONS AND PRIVATE ONE-ON-ONE BUSINESS PARTNERING MEETINGS.Description

Activity2 Activity2

FieldValueIRS element (for citing)
DescriptionSERVICESBIOTECHNOLOGY INDUSTRY ORGANIZATION'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIOTECHNOLOGY INDUSTRY ORGANIZATION INTERNATIONAL CONVENTION TO PROFESSIONAL DEVELOPMENT CONFERENCES FOR HUMAN RESOURCES AND BUSINESS DEVELOPMENT EXECUTIVES. BIOTECHNOLOGY INDUSTRY ORGANIZATION INTERNATIONAL CONVENTION - THE 2010 BIO INTERNATIONAL CONVENTION WAS HELD AT MCCORMICK PLACE IN CHICAGO, IL ON MAY 3-6, 2010. THE EVENT HOSTED MORE THAN 15,000 ATTENDEES FROM 65 COUNTRIES, AND 49 U.S. STATES. THE CONVENTION CONTINUED TO DRAW OVER 30% OF THE ATTENDANCE FROM COUNTRIES OUTSIDE THE U.S. WHICH INCLUDES MORE THAN 80 INTERNATIONAL PUBLIC OFFICIALS INCLUDING MINISTERS OF SCIENCE, AGRICULTURE, AND TECHNOLOGY.THE KEY ELEMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION INTERNATIONAL CONVENTION WERE:- EDUCATIONAL PROGRAMMING THAT INCLUDED FOUR DAYS WITH 170 BREAKOUT SESSIONS, 17 EDUCATIONAL TRACKS, MORE THAN 1,000 SPEAKERS, 2 KEYNOTE SESSIONS AND FIVE SUPER SESSIONS.- BIOTECHNOLOGY INDUSTRY ORGANIZATION BUSINESS FORUM WHERE 3,500 BUSINESS LEADERS FROM 2,125 COMPANIES PARTICIPATED IN MORE THAN 17,000 ONE-ON-ONE PARTNERING MEETINGS. (ALSO LISTED BELOW.) - BIOTECHNOLOGY INDUSTRY ORGANIZATION EXHIBITION HOSTED APPROXIMATELY 1,700 COMPANIES AT MCCORMICK PLACE WITH 180,000 NET SQUARE FEET OF EXHIBIT SPACE. ATTENDEES MINGLED AMONG THE 73 STATE, COUNTRY AND REGIONAL PAVILIONS AND ALSO THE 8 PRODUCT FOCUS ZONES.- PROFESSIONAL NETWORKING TOOK PLACE THROUGHOUT THE CONVENTION DURING THREE LARGE GENERAL EVENTS (WELCOME, EXHIBITION HOSPITALITY AND GALA), AS WELL AS SEVEN INVITE-ONLY RECEPTIONS (BIOTECHNOLOGY INDUSTRY ORGANIZATION BOARD OF DIRECTORS & 2010 STEERING COMMITTEE, CEO & HEALTH ADVOCATES, PUBLIC OFFICIALS, INVESTOR & BUSINESS DEVELOPMENT, BUSINESS FORUM, GLOBAL FOOD & AGRICULTURE, AND CEO.) CAPITAL FORMATION & BUSINESS DEVELOPMENT - THROUGH A PORTFOLIO OF EVENTS, BIOTECHNOLOGY INDUSTRY ORGANIZATION SUPPORTS THE CAPITAL FORMATION AND BUSINESS DEVELOPMENT NEEDS OF HUNDREDS OF SMALL, INNOVATIVE COMPANIES THAT FORM THE BASIS OF THE BIOTECHNOLOGY INDUSTRY. THESE PROGRAMS FACILITATE CRITICAL CAPITAL FORMATION AND PARTNERSHIPS, AND PROVIDE PROFESSIONAL SERVICES. THROUGHOUT THE YEAR, BIOTECHNOLOGY INDUSTRY ORGANIZATION HOSTS OR CO-HOSTS NINE NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS. THESE 2010 CONFERENCES BELOW SERVED MORE THAN 12,000 MEMBER AND NON-MEMBER ATTENDEES, AND INCLUDED MORE THAN 30,000 PARTNERING MEETINGS AND 950 COMPANY PRESENTATIONS OVER 10 DAYS OF OFFICIAL PROGRAMMING. THE 2010 U.S. PROGRAM INCLUDED: - BIOTECHNOLOGY INDUSTRY ORGANIZATION CEO & INVESTOR CONFERENCE, NEW YORK CITY, NY, FEBRUARY 8-9- BIOTECHNOLOGY INDUSTRY ORGANIZATION - WINDHOVER, NEW YORK CITY, NY, FEBRUARY 23-25- BUSINESS FORUM AT THE BIOTECHNOLOGY INDUSTRY ORGANIZATION INTERNATIONAL CONVENTION, CHICAGO, IL, MAY 4-6- BIOTECHNOLOGY INDUSTRY ORGANIZATION INVESTOR FORUM, SAN FRANCISCO, CA, OCTOBER 5-7BIO ALSO ORGANIZES, HOSTS, OR ASSISTS WITH HOSTING, FIVE OF THE LARGEST BIOTECH MEETINGS OUTSIDE OF THE U.S.; THE 2010 THE PROGRAM INCLUDED:- BIOTECHNOLOGY INDUSTRY ORGANIZATION -ASIA, TOKYO, JAPAN, JANUARY 25-26- BIOTECHNOLOGY INDUSTRY ORGANIZATION -EUROPE SPRING, BARCELONA, SPAIN, APRIL 8-10- BIOTECHNOLOGY INDUSTRY ORGANIZATION INDIA, HYDERABAD, INDIA, SEPTEMBER 21-22- BIOTECHNOLOGY INDUSTRY ORGANIZATION -EUROPE FALL, MUNICH, GERMANY, NOVEMBER 15-17IN 2010, BIOTECHNOLOGY INDUSTRY ORGANIZATION ALSO PROVIDED COST-EFFECTIVE EDUCATIONAL PROGRAMS TO HELP EXECUTIVES FROM SMALL COMPANIES. THESE WORKSHOPS, FOCUSED ON EXECUTIVE PRESENTATION SKILLS AND BASIC AND ADVANCED BUSINESS DEVELOPMENT SKILLS, WERE HELD THROUGHOUT THE YEAR IN VARIOUS LOCATIONS AROUND THE US AND GERMANY.HUMAN RESOURCES - IN 2010, THE ANNUAL BIOTECHNOLOGY INDUSTRY ORGANIZATION HUMAN RESOURCES CONFERENCE WAS HOSTED IN CHICAGO, IL ON MAY 5-7 IN CONJUNCTION WITH THE BIOTECHNOLOGY INDUSTRY ORGANIZATION INTERNATIONAL CONVENTION. IN ATTENDANCE WERE APPROXIMATELY 150 HUMAN RESOURCES PROFESSIONALS TO LEARN ABOUT TRENDS IN COMPENSATION, RETENTION, EMPLOYMENT, RECRUITMENT AND TO BUILD AND EXPAND THEIR EXPERTISE IN THE TECHNICAL AND BUSINESS AREAS OF THEIR PROFESSION.Description
FieldValueIRS element (for citing)
Described In501 C30DescribedIn501C3
Schedule B Required0ScheduleBRequired
Political Activities1PoliticalActivities
Subject To Proxy Tax1SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations0GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity0RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With1096166NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees182NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income1UnrelatedBusinessIncome
Form990-T Filed1Form990-TFiled
Foreign Financial Account1ForeignFinancialAccount
Name Of Foreign CountryINNameOfForeignCountry
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members109NbrVotingGoverningBodyMembers
Number Independent Voting Members109NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs1ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders1MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1A SCOTT WHITAKERBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number2029629200TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW STE 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (126 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationOfficerOfficerKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
BEEMAN DONALD
MEMBER5.00X000
BIENAIME JEAN-JACQUES
MEMBER5.00X000
BOGER JOSHUA
MEMBER5.00X000
BONANNI FABRIZIO
SECRETARY5.00X000X
BORISY ALEXIS
MEMBER5.00X000
BORMANN BJ
MEMBER5.00X000
CLARK IAN
MEMBER5.00X000
COHEN RON
MEMBER5.00X000X
COLES N
MEMBER5.00X000
CONWAY ROBERT
MEMBER5.00X000
CROWLEY JOHN
MEMBER5.00X000
DE RUITER TJERK
MEMBER5.00X000X
DEBETHIZY J DONALD
MEMBER5.00X000
DOERFLER DOUGLAS
MEMBER5.00X000
DUNCAN GREG
MEMBER5.00X000
DUNSIRE DEBORAH
MEMBER5.00X000
ECKES PETER
MEMBER5.00X000
EGGERT CHARLES
MEMBER5.00X000
ELLERBUSCH SUSAN
MEMBER5.00X000
ENGLE STEVEN
MEMBER5.00X000
ENO RICHARD
MEMBER5.00X000
FIROUZ FEREYDOUN
MEMBER5.00X000
FISCHER PAUL
MEMBER5.00X000
FRITZ CAROLYN
MEMBER5.00X000
GATTO STEPHEN
MEMBER5.00X000
GERBERDING JULIE
MEMBER5.00X000
GERMANO GENO
MEMBER5.00X000
GOLD MITCHELL
MEMBER5.00X000
GORMLEY GLENN
MEMBER5.00X000
GOWEN MAXINE
MEMBER5.00X000
GREENLEAF PETER
MEMBER5.00X000
GRUBER PATRICK
MEMBER5.00X000
GUTTERSON NEAL
MEMBER5.00X000
HALE DAVID
MEMBER5.00X000
HA-NGOC TUAN
MEMBER5.00X000
HASTINGS PAUL
MEMBER5.00X000
HERNDON RUSSELL
MEMBER5.00X000
HOPPENOT HERV
MEMBER5.00X000
JUNIUS DANIEL
MEMBER5.00X000
KAILIAN VAUGHN
MEMBER5.00X000
KARSEN PERRY
MEMBER5.00X000
KING RACHEL
MEMBER5.00X000
KOENIG SCOTT
MEMBER5.00X000
KUENKER KAY
MEMBER5.00X000
LEAHY EMER
MEMBER5.00X000
LEFF JONATHAN
MEMBER5.00X000
LEFTEROFF TRACY
MEMBER5.00X000
LEONARD JOHN
MEMBER5.00X000
LUNDBERG JAN
MEMBER5.00X000
MARAGANORE JOHN
MEMBER5.00X000
MATHERS THOMAS
MEMBER5.00X000
MCCAULEY GORDON
MEMBER5.00X000
MEDFORD RUSSELL
MEMBER5.00X000
MEEKER DAVID
MEMBER5.00X000
MENDELSON ALAN
MEMBER5.00X000
MENTO STEVEN
MEMBER5.00X000
MILLIGAN JOHN
MEMBER5.00X000
MOCH KENNETH
MEMBER5.00X000
MONROE ADAM
MEMBER5.00X000
MORGAN DAVID
MEMBER5.00X000
MORRIS ARLENE
MEMBER5.00X000
MYERS DAN
MEMBER5.00X000
NELSEN LITA
MEMBER5.00X000
NICHTBERGER STEVEN
MEMBER5.00X000
NICOLAIDES NICHOLAS
MEMBER5.00X000
OKARMA THOMAS
MEMBER5.00X000
PAKIANATHAN DEEPA
MEMBER5.00X000
PARKINSON ROBERT
MEMBER5.00X000
PAYA CARLOS
MEMBER5.00X000
PELTZ STUART
MEMBER5.00X000
PETERSON KRISTINE
MEMBER5.00X000
PISANO WAYNE
MEMBER5.00X000
POPS RICHARD
MEMBER5.00X000
PREUSS DAPHNE
MEMBER5.00X000
PURCELL DENNIS
MEMBER5.00X000
PYOTT DAVID
MEMBER5.00X000
RANIERI JOHN
MEMBER5.00X000
RHODES WILLIAM
MEMBER5.00X000
RIVA CARLOS
MEMBER5.00X000
ROBIN HOWARD
MEMBER5.00X000
RODELL TIMOTHY
MEMBER5.00X000
ROWE JEFF
MEMBER5.00X000
RYDER STEVEN
MEMBER5.00X000
SANDS ARTHUR
MEMBER5.00X000
SAPIRSTEIN JAMES
MEMBER5.00X000
SCHNEIDER JOACHIM
MEMBER5.00X000X
SCHULZE GAIL
MEMBER5.00X000
SHAW ALAN
MEMBER5.00X000
SHERWIN STEPHEN
BOARD CHAIR5.00X000X
SIEGEL JAY
MEMBER5.00X000
SKALETSKY MARK
TREASURER5.00X000X
SKURLA JOSEPH
MEMBER5.00X000
STANDLEE CHRISTOPHER
MEMBER5.00X000
STEINER GERALD
MEMBER5.00X000
STOTISH RONALD
MEMBER5.00X000
STRAHLMAN ELLEN
MEMBER5.00X000
SULLIVAN EDDIE
MEMBER5.00X000
THAKRAR ATUL
MEMBER5.00X000
TUTTLE STEVEN
MEMBER5.00X000
VAN BOKKELEN GIL
MEMBER5.00X000
VAN WART HAROLD
MEMBER5.00X000
VERBRUGGEN MARC
MEMBER5.00X000
WATKINS H THOMAS
MEMBER5.00X000X
WELLS BARBARA
MEMBER5.00X000
WELSH HUGH
MEMBER5.00X000
WOLFSON JONATHAN
MEMBER5.00X000
WONG MARK
MEMBER5.00X000
ZAKES BRADFORD
MEMBER5.00X000
ZERBE ROBERT
MEMBER5.00X000
GREENWOOD JAMES
CEO & PRESIDENT40.0011590640397922X
MURPHY EARLY LISA
SR VP, FIANNCE & ADMIN & CFO40.00482949041078X
WHITAKER A SCOTT
COO40.00682980049742X
DILENGE THOMAS
GENERAL COUNSEL40.00465415050663X
EISENBERG ALAN
EXECUTIVE VP, EMERGING COMPANIES SECTION & BUS DEV40.00494017050393X
DEL MONTE BRENT
VP, FEDERAL GOVT RELATIONS40.00441204041964X
ERICKSON BRENT
EXECUTIVE VP, INDUSTRIAL & ENVIRONMENT SECTION40.00376377048853X
BOMER SHARON
EXECUTIVE VP, FOOD & AGRICULTURE SECTION40.00273969051581X
JOSEPH JEFFREY
VP, COMMUNICATIONS40.00382480047384X
FINAN AMY
VP, CORPORATE DEVELOP & MARKETING40.00334340042467X
LYCETT ROBERTA
VP, CONVENT & CONFERENCES40.00328815046684X
RADCLIFFE SARA
EXE VP, HEALTH POLICY SECTION40.00345866042119X
DARRAGH SEAN
EXE VP, INT'L AFFAIRS40.00409220050552X
KELLY PATRICK
VP, STATE GOVT RELATIONS & ALLIANCE DEVELOP40.00307195045306X
DENNIS SANDRA
DEPUTY GENERAL COUNSEL40.00277504045444X
SAUER HANSJORG
DEPUTY GENERAL COUNSEL40.00259671043431X
MCHUGH PETER
COMPLIANCE OFFICER DEPUTY GENERAL COUNSEL40.00221653042809X
FieldValueIRS element (for citing)
Total Reportable Comp From Org7242719TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation1138392TotalOtherCompensation
Number Individuals GT100 K66NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
FREEMAN COMPANIES
1600 VICEROY SUITE 100DALLASTX75247CONVENTION & CONFERENCES SERVICES1635358
PROJECTION INC
PO BOX 890472CHARLOTTENC282890472VIDEO SERVICES1005439
FIXATION MARKETING
4340 EAST-WEST HWY SUITE 200BETHESDAMD208144411MARKETING949697
RHODE PLANNING & MGMT SOLUTIONS INC
42 LADD STREET SUITE 302EAST GREENWICHRI02818TRANSPORTATION SERVICES450044
HOGAN & LOVELLS LLP
555 THIRTEENTH ST NWWASHINGTONDC200041109LEGAL SERVICES415973
FieldValueIRS element (for citing)
Number Of Contractors GT100 K64NumberOfContractorsGT100K

Program Service Revenue ProgramServiceRevenue (4 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncomeUnrelated Business RevenueUnrelatedBusinessRevenueExclusionExclusionAmount
CONFERENCE/MEETING REV5418003248158632228325253261
MEMBERSHIP DUES9000992218248722182487
BUSINESS SOLUTIONS9000992815963$2,815,963
PUBLICATION ADVERTISIN5418001887334218531
FieldValueIRS element (for citing)
Total Program Service Revenue57498909TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column1607679TotalRevenueColumn
Exclusion$1,607,679ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities64338691Securities
Other943116Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities62410761Securities
Other1000490Other

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities1927930Securities
Other-57374Other

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column1870556TotalRevenueColumn
Exclusion$1,870,556ExclusionAmount

Other Revenue Misc OtherRevenueMisc

FieldValueIRS element (for citing)
DescriptionINTERNET REVENUESDescription
Business Code900099BusinessCode
Total Revenue Column42100TotalRevenueColumn
Related Or Exempt Function Income42100RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Other Revenue42100TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column61019244TotalRevenueColumn
Related Or Exempt Function Income54453254RelatedOrExemptFunctionIncome
Unrelated Business Revenue271792UnrelatedBusinessRevenue
Exclusion$6,294,198ExclusionAmount

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total6678329Total

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total13759284Total

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total634398Total

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total1337283Total

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total986867Total

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total249108Total

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total73117Total

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total2986109Total

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total278820Total

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total5437708Total

Advertising Advertising

FieldValueIRS element (for citing)
Total236121Total

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total1853258Total

Occupancy Occupancy

FieldValueIRS element (for citing)
Total3783592Total

Travel Travel

FieldValueIRS element (for citing)
Total1042596Total

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total15899936Total

Interest Interest

FieldValueIRS element (for citing)
Total4782Total

Payments To Affiliates PaymentsToAffiliates

FieldValueIRS element (for citing)
Total1102863Total

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total1186298Total

Other Expenses OtherExpenses (5 entries)

DescriptionDescriptionTotalTotal
OUTREACH618392
PUBLIC RELATIONS278432
BAD DEBT EXPENSE195506
SALES & TAX91068
MISCELLANEOUS20880

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total15428Total

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total58750175Total

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY11568885BOY
EOY6979800EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY1298340BOY
EOY1805535EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY1733438BOY
EOY2907323EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis11437276LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec6585164LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY5443048BOY
EOY4852112EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY41123212BOY
EOY48535212EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY581361BOY
EOY334031EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY61748284BOY
EOY65414013EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY6922038BOY
EOY8055493EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY11870408BOY
EOY12037740EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY6562139BOY
EOY6371762EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY25354585BOY
EOY26464995EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY36393699BOY
EOY38949018EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY36393699BOY
EOY38949018EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY61748284BOY
EOY65414013EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses2269069ReconcilationRevenueExpenses
Reconcilation Other Changes286250ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement SeparateXFinancialStatementSeparate
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Political Expenditures1000PoliticalExpenditures
Amt Expended For527 Activities1000AmtExpendedFor527Activities
Total Exmpt Function Expenditures1000TotalExmptFunctionExpenditures
Form1120 Pol Filed1Form1120PolFiled

Sec527 Pol Orgs Sec527PolOrgs

Name Of527 Organization NameOf527Organization

FieldValueIRS element (for citing)
Business Name Line1FRIENDS OF MARTIN O'MALLEYBusinessNameLine1

Address US AddressUS

FieldValueIRS element (for citing)
Address Line1218 E LEXINGTON STREET SUITE 602AddressLine1
CityBALTIMORECity
StateMDState
ZIP Code21202ZIPCode
FieldValueIRS element (for citing)
EIN521677368EIN
Amt Pd From Internal Funds1000AmtPdFromInternalFunds
FieldValueIRS element (for citing)
Substantially All Dues Nondeduct0SubstantiallyAllDuesNondeduct
Only In House Lobbying0OnlyInHouseLobbying
Agree To Carryover Prior Year1AgreeToCarryoverPriorYear
Dues Assessments22182487DuesAssessments
Non Ded Lobby Political Current8440000NonDedLobbyPoliticalCurrent
Non Ded Lobby Political Carryover3731NonDedLobbyPoliticalCarryover
Non Ded Lobby Political Total8443731NonDedLobbyPoliticalTotal
Aggr Amt Reported In Dues Notices8429345AggrAmtReportedInDuesNotices
Amount To Be Carried Over14386AmountToBeCarriedOver

Form990 Schedule C Part IV Form990ScheduleCPartIV

FieldValueIRS element (for citing)
IdentifierORGANIZATIONS DIRECT AND INDIRECT POLITICAL CAMPAIGN ACTIVITIES:Identifier
Return ReferencePART I-A, LINE 1:ReturnReference
ExplanationCONTRIBUTION TO STATE CAMPAIGN IN SUPPORT OF CANDIDATE.Explanation

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovements

FieldValueIRS element (for citing)
Other Cost Or Other Basis7882920OtherCostOrOtherBasis
Depreciation3791737Depreciation
Book Value4091183BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis3554356OtherCostOrOtherBasis
Depreciation2793427Depreciation
Book Value760929BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings4852112TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities (2 entries)

DescriptionDescriptionAmountAmount
CAPITAL LEASE OBLIGATION$116,172
DEFERRED RENT$6,255,590
FieldValueIRS element (for citing)
Total Of Amounts6371762TotalOfAmounts
Total Revenue61019244TotalRevenue
Total Expenses58750175TotalExpenses
Excess Or Deficit For Year2269069ExcessOrDeficitForYear
Net Unrealized GL On Investments151633NetUnrealizedGLOnInvestments
Other$134,617OtherAmount
Total Adjustments286250TotalAdjustments
Excess Or Deficit Per FS2555319ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt61614860TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments151633NetUnrealizedGainsInvestments
Other Revenues665429OtherRevenues
Revenue Not Rptd F990817062RevenueNotRptdF990
Revenue Subtotal60797798RevenueSubtotal
Investment Expenses Not Included278820InvestmentExpensesNotIncluded
Other Revenues Not Included-57374OtherRevenuesNotIncluded
Revenue Not Rptd On Fin Stmt221446RevenueNotRptdOnFinStmt
Total Revenue Per Form99061019244TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt59059541TotExpensesEtcAuditedFinclStmt
Other Expenses Included588186OtherExpensesIncluded
Expenses Not Rptd F990588186ExpensesNotRptdF990
Expenses Subtotal58471355ExpensesSubtotal
Investment Expenses Not Included2278820InvestmentExpensesNotIncluded2
Expenses Not Rptd On Fin Stmt278820ExpensesNotRptdOnFinStmt
Total Expenses Per Form99058750175TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (5 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:PART X:THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE AS A SECTION 501(A) ORGANIZATION. HOWEVER, THE ORGANIZATION IS SUBJECT TO FEDERAL AND DISTRICT OF COLUMBIA TAXES ON ITS UNRELATED BUSINESS INCOME. THE ORGANIZATION ADOPTED THE INCOME TAX STANDARD FOR UNCERTAIN INCOME TAX POSITIONS. THE ORGANIZATION EVALUATED ITS TAX POSITIONS AND DETERMINED THAT ITS TAX POSITIONS ARE MORE-LIKELY-THAN-NOT TO BE SUSTAINED ON EXAMINATION. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL, STATE AND LOCAL AUTHORITIES. THE TAX RETURNS FOR THE FISCAL YEARS ENDED 2007 TO 2009 ARE OPEN FOR EXAMINATION BY FEDERAL, STATE AND LOCAL AUTHORITIES.
PART XI, LINE 8 - OTHER ADJUSTMENTS:CBI REVENUE 53,903. CBI LOBBYING FUND REVENUE 425,500. FOOD & AG INITIATIVES REVENUE 186,026. FOOD & AG INITIATIVES EXPENSES -105,312. CBI LOBBYING FUND EXPENSE -425,500.
PART XII, LINE 2D - OTHER ADJUSTMENTS:CBI 53,903. CBI LOBBYING FUND 425,500. FOOD & AG INITIATIVES REVENUE 186,026.
PART XII, LINE 4B - OTHER ADJUSTMENTS:LOSS ON DISPOSAL OF FIXED ASSETS -57,374.
PART XIII, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG INITIATIVES EXPENSES 105,312. LOSS ON DISPOSAL OF ASSETS 57,374. CBI LOBBYING FUND 425,500.

Schedule F IRS990ScheduleF

Accts Actvs Out US Table AcctsActvsOutUSTable (3 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EUROPE01PROGRAM SERVICESCONFERENCE83887
EAST ASIA AND THE PACIFIC02PROGRAM SERVICESCONFERENCE515701
INDIA03PROGRAM SERVICESCONFERENCE342725
FieldValueIRS element (for citing)
Subtotal Number Of Employees6SubtotalNumberOfEmployees
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Employees6TotalNumberOfEmployees
Subtotal Amount Spent942313SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent942313TotalAmountSpent
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierMETHOD USED TO ACCCOUNT FOR EXPENDITURES:Identifier
ExplanationSCHEDULE F, PART I, LINE 3: EXPENDITURES ARE ACCOUNTED FOR ON THE ACCRUAL BASISExplanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelXFirstClassOrCharterTravel
Travel For CompanionsXTravelForCompanions
Club Dues Or FeesXClubDuesOrFees
Written Policy Re T And E Expenses1WrittenPolicyReTAndEExpenses
Substantiation Required1SubstantiationRequired
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan1SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement

Form990 Schedule J Part II Form990ScheduleJPartII (17 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
GREENWOOD JAMES
799064036000000031992607799601556986000
MURPHY EARLY LISA
3717540111195000299260111520524027000
WHITAKER A SCOTT
5254800157500000299260198160732722000
DILENGE THOMAS
3577900107625000299260207370516078000
EISENBERG ALAN
3642480129769000299260204670544410000
DEL MONTE BRENT
3394980101706000299260120380483168000
ERICKSON BRENT
311377065000000299260189270425230000
BOMER SHARON
228969045000000297110218700325550000
JOSEPH JEFFREY
293689088791000262510211330429864000
FINAN AMY
256340078000000298080126590376807000
LYCETT ROBERTA
252535076280000299260167580375499000
RADCLIFFE SARA
285866060000000299260121930387985000
DARRAGH SEAN
314720094500000299260206260459772000
KELLY PATRICK
236470070725000297880155180352501000
DENNIS SANDRA
261004016500000299260155180322948000
SAUER HANSJORG
242171017500000279130155180303102000
MCHUGH PETER
205153016500000272910155180264462000

Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)

Return ReferenceReturnReferenceExplanationExplanation
PART I, LINE 1AFIRST CLASS OR CHARTER TRAVEL -- JAMES GREENWOOD $11,653 NOT INCLUDED IN INCOME FIRST CLASS OR CHARTER TRAVEL -- ALAN EISENBERG $1,511 NOT INCLUDED IN INCOME FIRST CLASS OR CHARTER TRAVEL -- SEAN DARRAGH $5,897 NOT INCLUDED IN INCOME TRAVEL FOR COMPANIONS -- JAMES GREENWOOD $6,215 NOT INCLUDED IN INCOME HEALTH OR SOCIAL CLUB DUES -- ALAN EISENBERG $780 NOT INCLUDED IN INCOME
PART I, LINE 4BJAMES GREENWOOD 457(F) PLAN $290,000

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (10 entries)

IdentifierIdentifierExplanationExplanationReturn ReferenceReturnReference
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 2BASED ON A RESPONSE TO A SURVEY DISTRIBUTED TO EACH MEMBER OF BIOTECHNOLOGY INDUSTRY ORGANIZATION'S BOARD OF DIRECTORS, FIVE MEMBERS OF THE BOARD -- MAXINE GOWEN, DAVID HALE, DAVID PYOTT, JONATHAN WOLFSON AND SCOTT KOENIG -- INDICATED BUSINESS RELATIONSHIPS WITH OTHER MEMBERS OF THE BOARD.
FORM 990, PART VI, SECTION A, LINE 4THE BYLAWS FOR BIOTECHNOLOGY INDUSTRY ORGANIZATION WERE MODIFIED TWICE IN 2010. FIRST, IN MAY 2010, THE BYLAWS WERE MODIFIED TO CREATE NO MORE THAN TWO "CHAIR EMERITUS" POSITIONS ON THE BOARD. SECOND, IN DECEMBER 2010, THE BYLAWS WERE MODIFIED TO ADD A NEW SUBCATEGORY OF "CORE MEMBER" TO ALLOW FOR A NEW GROUPING KNOWN AS "NON-DOMESTIC COMPANIES."
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS - ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS - ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY; (C) AFFILIATE MEMBERS - ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS; (D) CENTER MEMBERS - ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP, THAT IS SPONSORED BY A STATE, REGION OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AFOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CFO. THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, COO, CFO AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD FOR REVIEW, QUESTIONS AND/OR COMMENTS, AND THEN SENT TO THE BIOTECHNOLOGY INDUSTRY ORGANIZATION EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS AS WELL. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
BIOTECHNOLOGY INDUSTRY ORGANIZATION TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIOTECHNOLOGY INDUSTRY ORGANIZATION TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIOTECHNOLOGY INDUSTRY ORGANIZATION'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIOTECHNOLOGY INDUSTRY ORGANIZATION'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIOTECHNOLOGY INDUSTRY ORGANIZATION'S GENERAL COUNSEL REGULARLY ADVISES BIOTECHNOLOGY INDUSTRY ORGANIZATION'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIOTECHNOLOGY INDUSTRY ORGANIZATION ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIOTECHNOLOGY INDUSTRY ORGANIZATION POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIOTECHNOLOGY INDUSTRY ORGANIZATION HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIOTECHNOLOGY INDUSTRY ORGANIZATION UNDERTAKES A QUESTIONNAIRE SENT TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIOTECHNOLOGY INDUSTRY ORGANIZATION. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT MAY RESULT IN RECUSAL OR OTHER APPROPRIATE RESTRICTIONS ON THE INDIVIDUAL'S PARTICIPATION OR ACTIVITIES WITHIN BIOTECHNOLOGY INDUSTRY ORGANIZATION, INCLUDING WHERE APPROPRIATE TERMINATION.FORM 990, PART VI, SECTION B, LINE 12C
IN 2008, THE EXECUTIVE AGREEMENT FOR THE PRESIDENT AND CEO OF BIOTECHNOLOGY INDUSTRY ORGANIZATION WAS RENEGOTIATED AND RENEWED. THE COMPENSATION HE RECEIVED IS DETAILED THROUGH THIS EXECUTIVE AGREEMENT. THE BIOTECHNOLOGY INDUSTRY ORGANIZATION EXECUTIVE COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BIOTECHNOLOGY INDUSTRY ORGANIZATION BOARD MEMBERS, LEADS AND UNDERTAKES THIS PROCESS. THE MEMBERS OF THE EXECUTIVE COMMITTEE WERE ASSISTED AND COUNSELED, CONTEMPORANEOUSLY, BY BOTH INDEPENDENT OUTSIDE LEGAL COUNSEL WHO IS AN EXPERT IN THIS AREA OF THE LAW, AND AN INDEPENDENT OUTSIDE CONSULTANT THAT PROVIDED BENCHMARKING SERVICES AND INFORMATION ON EXECUTIVE COMPENSATION ISSUES. THE BIOTECHNOLOGY INDUSTRY ORGANIZATION EXECUTIVE COMMITTEE, IN CONSULTATION WITH THE FULL BOARD, APPROVED THE EXECUTIVE AGREEMENT FOR THE BIOTECHNOLOGY INDUSTRY ORGANIZATION PRESIDENT AND CEO. IN 2010, THE BIOTECHNOLOGY INDUSTRY ORGANIZATION EXECUTIVE COMMITTEE EVALUATED THE PERFORMANCE OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION PRESIDENT AND CEO UNDER THIS EXECUTIVE AGREEMENT, AND BASED ON THIS PERFORMANCE EVALUATION, DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR. FORM 990, PART VI, SECTION B, LINE 15B: DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER LEADS AND UNDERTAKES THIS PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION.FORM 990, PART VI, SECTION B, LINE 15
THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.FORM 990, PART VI, SECTION C, LINE 19
CHANGES IN NET ASSETS OR FUND BALANCES:NET UNREALIZED GAINS ON INVESTMENTS: 151,633. CBI REVENUE 53,903. CBI LOBBYING FUND REVENUE 425,500. FOOD & AG INITIATIVES REVENUE 186,026. FOOD & AG INITIATIVES EXPENSES -105,312. CBI LOBBYING FUND EXPENSE -425,500. TOTAL TO FORM 990, PART XI, LINE 5: 286,250.FORM 990, PART XI, LINE 5:

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.